IL2 and melanoma: Pre-treatment with IL-27 resulted in lower IL-2 production in the co-culture that was specifically reversed by addition of an anti-PD-L1 neutralizing Ab (Figure 5D), indicating that PD-L1 induction by IL-27 on melanoma cells decreased T-cell activation as expected.